M15-739
ClinicalTrials.gov NCT03374917
Research payments
$312,880
Through program year 2020, $312,880 in research payments was reported against M15-739, across 57 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03374917
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $30,537 | 1 |
| 2019 | Research | $282,343 | 56 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Nirav Pavasia Dallas, TX Named on 15 payments
- Michael Pourfar New York, NY Named on 8 payments
- David Shprecher Salt Lake City, UT Named on 5 payments
- Khashayar Dashtipour Loma Linda, CA Named on 5 payments
- Neal Hermanowicz Palm Springs, CA Named on 4 payments
- Michal Gostkowski Cleveland, OH Named on 4 payments
- Rajesh Pahwa Kansas City, KS Named on 4 payments
- John Slevin Lexington, KY Named on 3 payments
- Alberto Espay Cincinnati, OH Named on 3 payments
- Kathrin Lafaver Louisville, KY Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.